Second-generation cephalosporins.
Glatt
A E
AE
D001424:Bacterial Infections / Q000188:drug therapy*; D001442:Bacteroides Infections / Q000188:drug therapy; D002435:Cefamandole / Q000031:analogs & derivatives / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use; D015790:Cefonicid; D002440:Cefoxitin / Q000627:therapeutic use; D002444:Cefuroxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D006069:Gonorrhea / Q000188:drug therapy; D006192:Haemophilus Infections / Q000188:drug therapy; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013329:Structure-Activity Relationship
D002511:Cephalosporins; D002435:Cefamandole; D015790:Cefonicid; D002440:Cefoxitin; D002437:Cefazolin; D002444:Cefuroxime